Latest Cambridge News | Page 12

Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
Tokyo Tech Academy of Energy and Informatics holds online kick-off ceremony, workshop
New book upends thinking on why people have ‘bad beliefs’
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
Blueprint Reveals How Plants Build Sugar Transport Lane
Vaxzevria significantly boosted antibody levels against Omicron
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant 23 December
Ultomiris regulatory submission accepted under FDA Priority Review
Fourth man charged over abduction and home invasion at Sans Souci, NSW
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Tezspire approved in US for severe asthma
NSW latest Covid update as at 17 December
Powerledger: world’s first ‘new energy’ trading platform
Police charge three people over deliberately lit fires in Snug and Cambridge
Funding helps projects spring into action
NSW latest public Health Alert – New venues of concern in Newcastle
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant
NSW latest Covid update as at 16 December
NSW latest public Health Alert – Venue of concern in Newcastle 16 December
LOGOS consortium completes landmark $1.67 billion acquisition of warehousing and property components of Qube’s Moorebank Logistics
Ashurst advises National Express on all-share combination with Stagecoach
CSL Committed to mRNA Program
NSW police lay charges after fatal crash
Understanding mass influence activities is critical
Evusheld long-acting antibody combination authorised for emergency use
Griffith Golden Key Scholarship recipients are all smiles
AstraZeneca and Ionis sign deal to develop and commercialise eplontersen
AstraZeneca reinforces leadership in breast cancer at SABCS 2021 with new data underscoring ambition to redefine cancer care
Caught on Camera: Live Imaging of Transcription Using Active RNA Polymerase II-Specific Probes
Delivering more local investment and jobs at Momentum Energy
Human Rights Council President appoints Lynn Welchman of United Kingdom to serve on Commission of Inquiry on Syrian Arab Republic
Lynparza granted Priority Review in US for BRCA-mutated HER2-negative high-risk early breast cancer
Eftpos flicks switch on world-class AI anti-fraud technology to fortify online shopping security
New technology helps to improve sleep quality naturally
More than 20,000 vaccine doses administered yesterday; 144 cases; 1 death; 82 people in hospital – 9 people in ICU
Work underway on new Cambridge Police base
Combined Primary Schools Band and Choir Concert
KPMG Australia appoints Ian Silk as Special Advisor
Man charged as investigations into Dubbo shooting continue, NSW
AstraZeneca unveils Discovery Centre in Cambridge
Two Sydney men charged over 314kg heroin import
New analyses of two AZD7442 Covid Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
Received & Determined Development Applications 18 November
Two billion doses of AstraZeneca’s Covid vaccine supplied to countries across world less than 12 months after first approval
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
More than 22,000 vaccine doses given yesterday; 84 cases in hospital; 185 community cases
Polygenic scores go beyond risk prediction to identify causes of disease
SleepHub launches in Australia to help people improve their sleep